Dr. Daniel Horatio Cooper, MD

Dr. Cooper practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Cooper's NPI, 1700893005, was assigned on August 1, 2006. Dr. Cooper graduated from Loyola University Chicago Stritch School of Medicine in 2003. Dr. Cooper holds Missouri license 2006017158.

Dr. Cooper's primary practice is Washington University School of Medicine, at 4990 Childrens Pl, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 747-5192.

Dr. Cooper's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Cooper is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Cooper to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 5 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Cooper is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Cooper's licenses on file in 2 states: Missouri and Illinois.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, heart blockage, intermittent racing heartbeat (PSVT), pacemaker or defibrillator implantation, pacemaker replacement, sick sinus syndrome and ventricular tachycardia among the conditions Dr. Cooper treats.

CMS data shows 2,011 Medicare services from Dr. Cooper across 19 procedure codes in 2024, for 488 Medicare patients. Medicare paid $75,546 for them.

CMS counts 488 Medicare patients who saw Dr. Cooper in 2024. The largest group is 75 to 84, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 73, with 47% women.

In 2024, Dr. Cooper wrote 1,202 Medicare Part D claims for 258 patients. 72% of them were for generic drugs. CMS names the drug for 1,092 of them, across 16 drugs with 11 or more claims each, at $391,380 in total drug cost. In 2023, CMS named 913 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Cooper for performance year 2024, reported as part of a group. Dr. Cooper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of pacemaker insertion or repair by Dr. Cooper, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 36 papers to Dr. Cooper, published from 2005 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Electrocardiography, Tachycardia, Ventricular and Catheter Ablation. Dr. Cooper has published most often in Heart Rhythm. Dr. Cooper's most frequent co-authors are Phillip Stephan Cuculich, MD, Peter Alexander Noseworthy, MD and Mitchell N. Faddis, MD.

Dmand AI links Dr. Cooper to 3 clinical trials. Conditions studied include Atrial Fibrillation, Heart Failure and Tachycardia, Ventricular.

CMS Open Payments shows 727 general payments to Dr. Cooper from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Abbott Laboratories paid the most, $77,568.

Dmand AI lists 1 award for Dr. Cooper, most recently CMS Stage 1 EHR in 2012.

Dr. Cooper graduated from Loyola University Chicago Stritch School of Medicine in 2003. Dr. Cooper is a member of ACC.

Dr. Cooper is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.